Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil. [electronic resource]
Producer: 19990824Description: 354-9 p. digitalISSN:- 0020-7136
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- mortality
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Lymph Node Excision
- Lymphatic Metastasis
- Mastectomy
- Menopause
- Methotrexate -- administration & dosage
- Middle Aged
- Predictive Value of Tests
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Regression Analysis
- Survival Rate
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.